Palisade Bio (PALI) 10-Q2013 Q1 Quarterly report

Filed: 10 May 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accrued, advisor, ALSand, analyst, assuming, axial, bending, borrow, borrowing, breathe, bridging, bystructurally, cancer, cease, chest, circuitry, clinicaltrial, collateralized, commencedthePhase, corroborated, debt, deficit, die, disc, discount, discounted, dislocation, dosedtwo, drawn, embedded, enjoyable, equina, exempt, fact, fifteen, firm, firstnine, firstquarter, floor, framework, gap, Global, goodwill, gunshot, hard, hierarchical, hierarchy, hiring, hyperextension, hyperflexion, identical, impossible, improve, infection, inour, instrument, intervertebral, inventory, Itrial, lab, lender, loading, loan, Marman, Matching, mental, merger, MoleculePharmaceuticalCompound, mood, movement, muscle, nerve, nonrecurring, NSI, nurture, nurturing, observability, observable, ofthe, orcauda, orderly, partner, PCAOB, PhaseI, pleasure, point, prepaid, prime, productused, quoted, ramping, rebuilding, reclassification, recurrent, restoring, rotation, SCI, segregated, send, sensory, short, signal, slowly, spot, stab, stop, strike, subdivision, supplier, thereof, thetrial, thoracic, transmit, trauma, traumatic, travel, Tripoint, twitching, unadjusted, underway, underwriting, unipolar, variable, vascular, vehicle, vertebral, waiver, waste, weakening, worse

Removed: adjust, administered, Alexander, alleged, animal, aortic, apply, attestation, auditor, bearing, began, Black, budget, CA, carried, chemical, complication, confidence, consultant, Defense, deliverable, department, directly, encountered, entry, expired, feature, forfeited, fourth, gain, hold, implementation, Improper, injection, John, Jr, Judge, Jurisdiction, lose, mark, MD, milestone, Neurosurgery, Northern, notified, opposed, orally, painful, payment, periodic, Personal, PhD, plan, platform, Professor, program, proportional, remain, remediate, reneuron, reset, reverse, revisit, route, screening, settlement, spasticity, sponsored, stable, structure, supplement, support, transplanted, Venue, Zhang

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PALI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO

18 U.S.C. SECTION 1350 AND EXCHANGE ACT RULES 13a-14(b) AND 15d-14(b)

(Section 906 of the Sarbanes-Oxley Act of 2002)

In connection with the Quarterly Report of Neuralstem, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, I. Richard Garr, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operation of the Company.

Date: May 10, 2013

/s/ I. Richard Garr
Chief Executive Officer
Neuralstem, Inc.

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.